The Data Availability Illusion: Why 'Voluntary Guidelines' Are a Gift to Predatory Actors
Verified Researcher
May 22, 2024•4 min read

The Transparency Trap: When Flexibility Becomes a Loophole
The scholarly publishing industry is currently patting itself on the back for the STM Association’s new voluntary recommendations on medical and health data sharing. The narrative is comforting: we are finally moving away from generic, one-size-fits-all policies toward nuanced, domain-specific guidance. But let’s be clear-eyed about the stakes. In the high-stakes theater of medical publishing, "voluntary recommendations" are not progress; they are a retreat. By prioritizing flexibility for authors, we are inadvertently handing a master key to the predatory publishers and paper mills currently colonizing the health sciences.
Nuance is where the rot hides. By blessing subjective exceptions and vague language in data sharing protocols, we are not just helping honest researchers navigate privacy laws. We are handing a cheat sheet to the industry's worst actors. If a journal adopts a policy that is merely clear but flexible, a paper mill will have no trouble drafting a convincing excuse for why their fake clinical data cannot be touched. It is a gift for those looking to dodge the light.
The Rise of the 'Data Ghost' in Medical Publishing
We are entering an era of the "Data Ghost," where papers appear robust and compliant on the surface while the underlying evidence remains strategically unreachable. The STM’s focus on "defining what data means" and "handling exceptions" is a double-edged sword. While intended to reduce author burden, it creates a standardized vocabulary for obfuscation. In the hands of a predatory journal (or even a legacy publisher desperate for volume) these guidelines offer a veneer of legitimacy without the teeth of enforcement.
This trend is particularly dangerous in the medical field, where the "Publish or Perish" culture has evolved into a tribal ritual of status-seeking. As Matt Cannon, Associate Director for Open Science Programs at Taylor & Francis, recently noted in his discussion of the new STM recommendations, the goal is to help publishers provide clearer guidance to support responsible data sharing. However, the integrity of the record shouldn't depend on whether a publisher chooses to be clear; it must depend on whether the data actually exists and is verifiable.
Why 'Voluntary' is a Code Word for Vulnerability
The fundamental breakdown here is a refusal to demand raw data at the point of peer review. We talk about facilitating access, but without a hard mandate, it is all just theater. Predatory journals will be the first to adopt these STM guidelines. Why? Because it lets them signal quality on their homepages while continuing to churn out unverified nonsense. They will use these definitions as a shield, hiding behind loopholes large enough to drive a truck through.
We must stop treating data sharing as a courtesy and start treating it as a prerequisite for clinical claims. If the data cannot be audited, the paper is an advertisement, not science. The current system relies on the "Psychologist’s Delusion" (the belief that if we provide better instructions, people will stop cheating). They won't. They will just get better at following the instructions to cheat.
A Radical Blueprint for Medical Integrity
If we actually want to protect the medical record from the encroaching rot of predatory practices and fabricated data, we need to move beyond workshops and voluntary frameworks. Here are two structural reforms that would actually shift the needle:
First, we need a Zero Trust data mandate. Journals should require raw, de-identified patient data to be parked in a secure, third party repository before anyone even looks at the manuscript. If the data is not in the vault, the clock does not start. No exceptions for corporate secrets. If the findings are too sensitive to be audited by a reviewer, they are too secret to be called science. Second, we should swap Open Access fees for mandatory Data Verification Fees. Use that cash to hire forensic analysts who hunt for statistical red flags and image doctoring before anything is typeset.
The future of scholarly publishing isn't in better guidelines; it's in the death of the "trust me" model. As we approach 2027, the industry must decide if it wants to be a library of verified evidence or a repository of well-formatted claims. The STM recommendations are a polite start, but in the war against predatory science, politeness is a losing strategy.


Discussion (17)
Join the conversation
Login or create an account to share your thoughts.
Hard pass on this logic. If we over-regulate, we lose the speed of innovation.
Very interesting. I wonder how this applies to the new EU data regulations.
What about the ethics committees? Shouldn't they be the ones closing these gaps?
Excellent point about the 'Gift to Predatory Actors.' Reminds me of the early days of open access before we had proper licensing standards. Keep up the good work!
In my department, we see these 'voluntary' steps bypassed every single time there is a commercial incentive involved.
Predatory publishers are already gaming the system; providing them with a 'voluntary' loophole is like leaving the vault door cracked open.
Has anyone actually audited the 'specific guidance' mentioned in the original STM post? It's remarkably thin on actual consequences.
Spot on.
The illusion of availability is often worse than total opacity because it creates a false sense of security for the patients involved.
so basically we're just trusting them to be nice? lol good luck with that
Simply brilliant summary of the current landscape.
this is the most honest take on STM recommendations i have seen all year thanks
Regulatory capture in action. The authors of these guidelines are the ones who benefit from the loopholes.
i'm just here for the comments but this actually makes a lot of sense
Doesn't this ignore the fact that overly rigid mandates might stifle smaller research groups who lack the compliance budget?
it's all about the money as usual
The distinction between 'guideline' and 'enforcement' is where clinical integrity goes to die. We need mandates, not suggestions.